Interferon treatment trial appears to be a major breakthrough against COVID-19
TORONTO: The preliminary results of a clinical trial by a UK biotech suggests that an interferon inhalation treatment for COVID-19 reduces the number of patients needing intensive care. In the UK study, the treatment was delivered through a nebulizer and inhaled directly into the lungs of patients with coronavirus. The initial findings suggest the treatment…